Cooke & Bieler LP reduced its stake in shares of Perrigo Company plc (NYSE:PRGO – Free Report) by 12.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,037,041 shares of the company’s stock after selling 151,628 shares during the period. Cooke & Bieler LP’s holdings in Perrigo were worth $15,307,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Range Financial Group LLC acquired a new position in Perrigo during the third quarter valued at $2,975,000. Nisa Investment Advisors LLC grew its stake in Perrigo by 328.8% in the 3rd quarter. Nisa Investment Advisors LLC now owns 57,190 shares of the company’s stock valued at $844,000 after acquiring an additional 43,854 shares during the period. Abel Hall LLC raised its position in shares of Perrigo by 14.0% during the 3rd quarter. Abel Hall LLC now owns 14,630 shares of the company’s stock worth $216,000 after purchasing an additional 1,797 shares during the last quarter. SteelPeak Wealth LLC increased its position in shares of Perrigo by 20.8% during the third quarter. SteelPeak Wealth LLC now owns 22,369 shares of the company’s stock worth $330,000 after purchasing an additional 3,853 shares in the last quarter. Finally, TD Waterhouse Canada Inc. acquired a new stake in shares of Perrigo in the third quarter valued at about $1,621,000. Hedge funds and other institutional investors own 95.91% of the company’s stock.
Analyst Upgrades and Downgrades
PRGO has been the subject of a number of recent research reports. Weiss Ratings raised Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a research note on Thursday, August 6th. Wall Street Zen lowered shares of Perrigo from a “strong-buy” rating to a “buy” rating in a research report on Sunday, September 27th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $19.33.
Read Our Latest Stock Analysis on PRGO
Perrigo Stock Down 1.4%
Shares of NYSE PRGO opened at $15.95 on Thursday. The business’s fifty day simple moving average is $14.47 and its 200-day simple moving average is $12.20. The company has a current ratio of 2.32, a quick ratio of 1.32 and a debt-to-equity ratio of 1.31. The stock has a market cap of $2.21 billion, a P/E ratio of -1.27, a PEG ratio of 1.85 and a beta of 0.69. Perrigo Company plc has a 12-month low of $9.23 and a 12-month high of $22.02.
Perrigo (NYSE:PRGO – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.50 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.11. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. Perrigo had a negative net margin of 41.85% and a positive return on equity of 11.25%. The company’s revenue was down 3.1% on a year-over-year basis. During the same period last year, the business earned ($0.06) EPS. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. As a group, equities analysts predict that Perrigo Company plc will post 2.18 EPS for the current fiscal year.
Perrigo Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Friday, August 28th were paid a $0.29 dividend. The ex-dividend date was Friday, August 28th. This represents a $1.16 dividend on an annualized basis and a yield of 7.3%. Perrigo’s payout ratio is currently -9.27%.
Perrigo Company Profile
Perrigo Company plc is a global consumer self-care company that develops, manufactures and markets over-the-counter health products, wellness products and personal care items. Its portfolio includes products for allergy, pain relief, digestive health, skin care, smoking cessation, women’s health and other everyday health needs, along with vitamins, nutritional supplements and infant nutrition products.
Perrigo supplies products under its own brands, acquired brands and retailer-owned private-label labels.
See Also
- Five stocks we like better than Perrigo
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO – Free Report).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.
